Manufacturer
74 recalls in our database name Philips Respironics, Inc. as the manufacturing or recalling firm.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
The Philips Respironics Trilogy Evo home ventilator's obstruction alarm may not trigger within required timeframes, potentially delaying detection of airway blockages. Approximately 113,717 units are affected worldwide.
Philips Respironics Trilogy EV300 ventilators are recalled because the obstruction alarm may not trigger within required timeframes, potentially delaying detection of airway blockages. Over 113,000 units are affected worldwide.
Philips Respironics Trilogy Evo Universal ventilator software version 1.05.15.00 recalled because the obstruction alarm may fail to trigger within required timeframes, potentially delaying critical responses to airway obstruction.
The Philips Respironics Trilogy Evo O2 ventilator's obstruction alarm may not trigger promptly, taking up to four breaths to respond. This delay could prevent timely detection of a blocked airway in patients depending on the device for breathing support.
Philips Respironics Trilogy EV300 ventilators may deliver an incorrect amount of air when used with non-pneumatic nebulizers, potentially affecting respiratory support in dependent patients.
Philips Respironics Trilogy Evo O2 ventilators may not deliver the correct breathing support when used with non-pneumatic nebulizers. Verify nebulizer compatibility and contact Philips for guidance.
Philips Respironics Trilogy Evo Universal ventilators may have tidal volume discrepancies when used with non-pneumatic nebulizers. Approximately 113,717 units distributed worldwide are affected by this Class I recall.
Philips Respironics Trilogy Evo ventilators may deliver incorrect tidal volume to patients when used with non-pneumatic nebulizers. This discrepancy between set and delivered volume poses a risk to home-use patients.
Certain SimplyGo Mini battery kits contain a defective chip that may fail to charge or lose power during use, causing the oxygen concentrator to shut down. The defect affects 56 units distributed in six US states and Canada.
Philips is recalling 8 DreamStation Auto BiPAP ventilators due to a programming error that may result in incorrect device configuration. Affected units are distributed nationwide and in France.
Philips Respironics is recalling the DreamStation Auto Non-Continuous Ventilator due to a programming error that may result in incorrect device configuration affecting 28 units.
Philips Respironics has recalled 57 DreamStation Auto CPAP devices that may have a programming error causing incorrect device configuration. Affected units were distributed nationwide in the US and in France.
Philips Respironics recalled 5,958 BiPAP V30 Auto Ventilators worldwide due to incorrect labeling indicating use for respiratory failure patients. The device is not indicated for respiratory failure.
Philips Respironics recalls BiPAP A30 and BiPAP Hybrid A30 ventilators due to labeling deficiency. The devices do not indicate for use in patients with respiratory failure.
Philips Respironics BiPAP A40 ventilators are being recalled because they are not indicated for use in patients with respiratory failure. The device may not be appropriate for this patient population.
Philips Respironics Aeris EVO ventilators may accumulate aerosol deposits on the internal flow sensor, potentially causing inaccurate flow measurements.
Trilogy Evo Universal Ventilators (Model DS2000X11B) are recalled because in-line nebulizer configuration in certain locations could cause aerosol accumulation on the internal flow sensor, potentially resulting in inaccurate measurements.
Philips Respironics is recalling Trilogy Evo ventilators due to potential aerosol deposits on the internal flow sensor, which could cause inaccurate flow measurements during ventilation.
Philips Respironics is recalling 34,146 Trilogy EV300 ventilators due to potential aerosol accumulation on the internal flow sensor, which could cause inaccurate ventilation measurements.
Philips Respironics recalled 24,249 Trilogy Evo O2 ventilators because in-line nebulizer configurations may allow aerosol deposits to accumulate on the device's flow sensor, potentially causing inaccurate flow measurements.
Philips Respironics is recalling 1,322 Garbin Evo ventilators (Model LD2110X23B) worldwide due to potential aerosol accumulation that could cause inaccurate flow sensor readings, posing a risk to patient care.
Philips Respironics is recalling LifeVent EVO2 ventilators due to potential aerosol deposit accumulation on the internal flow sensor that could cause inaccurate measurements during ventilation.
Philips Respironics is issuing a mandatory software update (Version 1.05.10.00) for the Trilogy Evo Universal Ventilator to address safety issues identified in earlier recalls. Affected units should implement the update.
Philips Respironics is issuing a mandatory software update (Version 1.05.10.00) for Trilogy Evo EV300 ventilators to resolve previously identified safety issues. Approximately 90,910 US units and 56,273 international units are affected.
Philips Respironics is issuing a mandatory software update (Version 1.05.10.00) for Trilogy Evo ventilators worldwide to resolve identified safety issues. Users must apply the update and review the updated User Manual.